Skip to the page

Data / Drug companies / Viona Pharmaceuticals Inc

Viona Pharmaceuticals Inc: 106 products in the FDA NDC directory, labeler code 72578

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Viona Pharmaceuticals Inc (labeler code 72578) lists 106 products in the FDA National Drug Code Directory, covering 54 finished drugs by generic name. By type: 106 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 1, 2026.

The request: Watch Viona Pharmaceuticals Inc (FDA labeler code 72578): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72578
Products in commercial distribution
106
Packages
270
Finished drugs by generic name
54
Prescription products
106
Over the counter products
0
Controlled substance products
Schedule IV 2
Flagged as original packager
99 of 99 products that carry the flag
Started marketing in the last 12 months
19
Earliest marketing start
June 7, 2009
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)106100%

Products by type

TypeProductsShare
Prescription drugs106100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet4441.5%
Tablet, film coated1817%
Cream1110.4%
Capsule98.5%
Tablet, extended release65.7%
Ointment54.7%
Tablet, orally disintegrating54.7%
Gel43.8%
Solution21.9%
Shampoo10.9%
Lotion10.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Tranexamic Acid72578-220TabletGeneric drugs (ANDA)November 1, 2026
Mupirocin72578-130CreamGeneric drugs (ANDA)October 10, 2026
Ammonium lactate72578-203CreamGeneric drugs (ANDA)October 2, 2026
Tretinoin72578-155CreamGeneric drugs (ANDA)October 1, 2026
Candesartan cilexetil72578-160TabletGeneric drugs (ANDA)September 7, 2026
Candesartan cilexetil72578-159TabletGeneric drugs (ANDA)September 7, 2026
Candesartan cilexetil72578-158TabletGeneric drugs (ANDA)September 7, 2026
Candesartan cilexetil72578-157TabletGeneric drugs (ANDA)September 7, 2026
Diltiazem hydrochloride72578-202TabletGeneric drugs (ANDA)May 25, 2026
Diltiazem hydrochloride72578-201TabletGeneric drugs (ANDA)May 25, 2026
Diltiazem hydrochloride72578-200TabletGeneric drugs (ANDA)May 25, 2026
Diltiazem hydrochloride72578-199TabletGeneric drugs (ANDA)May 25, 2026
Cevimeline Hydrochloride72578-208CapsuleGeneric drugs (ANDA)April 15, 2026
Ivermectin72578-223TabletGeneric drugs (ANDA)February 27, 2026
Dapsone72578-178TabletGeneric drugs (ANDA)February 27, 2026
Dapsone72578-177TabletGeneric drugs (ANDA)February 27, 2026
Metronidazole72578-209GelGeneric drugs (ANDA)February 14, 2026
Prucalopride72578-222Tablet, film coatedGeneric drugs (ANDA)February 2, 2026
Prucalopride72578-221Tablet, film coatedGeneric drugs (ANDA)February 2, 2026
Methimazole72578-213TabletGeneric drugs (ANDA)September 10, 2025
Methimazole72578-212TabletGeneric drugs (ANDA)September 10, 2025
Ibuprofen and Famotidine72578-214TabletGeneric drugs (ANDA)June 1, 2025
Methenamine hippurate72578-175TabletGeneric drugs (ANDA)March 12, 2025
Ketoconazole72578-156ShampooGeneric drugs (ANDA)March 8, 2025
Lidocaine and prilocaine72578-165CreamGeneric drugs (ANDA)January 1, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.